prioritizing the optimal therapy for t1 bladder cancer: using the old and new
Published 1 year ago • 1.2K plays • Length 21:10Download video MP4
Download video MP3
Similar videos
-
15:03
t1 bladder cancer
-
17:36
management of high-grade t1 bladder cancer
-
14:13
point-counterpoint: muscle invasive bladder cancer–trimodal therapy perspective
-
20:29
neoadjuvant and adjuvant chemotherapy in bladder cancer
-
23:44
a review of aua/suo/astro guidelines for muscle invasive bladder cancer (mibc)
-
11:44
bladder cancer risk stratification: moving from the old to the new
-
14:46
enhanced techniques of non-muscle invasive bladder cancer detection
-
11:40
point-counterpoint: muscle invasive bladder cancer–cystectomy perspective
-
26:18
controversies in non-muscle invasive bladder cancer (nmibc): guidelines and beyond 2023
-
17:06
muscle invasive bladder cancer guidelines review
-
9:12
immunotherapy for nmibc: emerging and expanding indications
-
19:31
second line bladder cancer therapies when first line treatments fail
-
20:52
bladder cancer and immunotherapy
-
17:42
bladder-sparing trimodality therapy
-
5:49
optimal therapy is intravesical
-
24:32
bladder sparing tri-modal therapy updates
-
21:37
non-muscle invasive bladder cancer: guidelines-based approach
-
12:26
muscle invasive bladder cancer: 2018 guidelines
-
15:42
urinary markers in bladder cancer